NRx Pharmaceuticals (NRXP)
3.49
+0.06 (1.75%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
August 26, 2026 6:43 AM - StreetInsider
Form 8-K NRX Pharmaceuticals, For: Aug 17
August 17, 2026 8:00 AM - SEC Filing
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
August 17, 2026 7:00 AM - StreetInsider
Form 10-Q NRX Pharmaceuticals, For: Jun 30
August 14, 2026 4:37 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
August 10, 2026 6:50 AM - StreetInsider
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
August 7, 2026 4:01 PM - StreetInsider
FDA completes first-cycle review of NRx ketamine ANDA with packaging query
August 7, 2026 7:01 AM - StreetInsider
Form 8-K NRX Pharmaceuticals, For: Aug 07
August 7, 2026 7:01 AM - SEC Filing
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
August 7, 2026 7:00 AM - StreetInsider
Form 8-K NRX Pharmaceuticals, For: Jul 21
July 22, 2026 7:00 AM - SEC Filing
New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.
June 27, 2026 2:40 PM - StreetInsider
NRx Pharmaceuticals disputes Kadima claims amid arbitration
June 25, 2026 4:01 PM - StreetInsider
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
June 25, 2026 4:01 PM - StreetInsider
HOPE Therapeutics begins patient TMS treatments with Zeta navigation
June 25, 2026 7:00 AM - StreetInsider
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
June 25, 2026 7:00 AM - Globe NewsWire
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
June 25, 2026 7:00 AM - StreetInsider
Kadima sues NRx Pharmaceuticals over failed acquisition deal
June 24, 2026 1:19 PM - StreetInsider
Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition
June 24, 2026 1:18 PM - BizWire
Zeta Surgical begins TMS navigation treatments at Hope Therapeutics clinics
June 23, 2026 11:10 AM - StreetInsider
ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics
June 23, 2026 11:05 AM - PR NewsWire
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression
June 22, 2026 7:00 AM - StreetInsider
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
June 20, 2026 1:30 PM - StreetInsider
Full Article List
